Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capadenoson in Chronic Stable Angina
NCT00518921Phase 2Withdrawn
- Sponsor
- Bayer
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of capadenoson in angina pectoris, sponsored by Bayer. Planned start Mar 2008; status: withdrawn.
02
Drugs
capadenoson
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT00518921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00518921.